Professional DDS developing company -Anxo Pharmaceutical Company (ANXO, stock code: 6677) announced on 30th July that, a joint development agreement of psychiatric drugs has been signed with Shenzhen C company based on the idea of authorizing and profit-sharing. Shenzhen C company will be the sole agent of this field in China, and will also cooperate with ANXO to conduct relevant clinical trials and registration in order to grab the Chinese market share of special psychiatric drugs together.